Last reviewed · How we verify
Placebo Preventative
This drug is a placebo, meaning it has no active therapeutic effect.
This drug is a placebo, meaning it has no active therapeutic effect. Used for Prevention of symptoms in clinical trials.
At a glance
| Generic name | Placebo Preventative |
|---|---|
| Sponsor | Benaroya Research Institute |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not interact with any biological molecules or systems, and its effects are purely psychological or due to the natural course of the disease. The lack of therapeutic effect is intentional, allowing researchers to compare outcomes against a control group.
Approved indications
- Prevention of symptoms in clinical trials
Common side effects
- No adverse events
Key clinical trials
- Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children (NA)
- Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2 (PHASE3)
- Improving Care Through Azithromycin Research for Infants in Africa (PHASE3)
- Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome (PHASE2)
- Single-Center Phase II Double-Blind Trial of SAMe to Prevent Liver Cancer in MASLD-Related Cirrhosis (PHASE2)
- Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage (PHASE4)
- Obeticholic Acid for Prevention in Barrett's Esophagus (PHASE2)
- Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo Preventative CI brief — competitive landscape report
- Placebo Preventative updates RSS · CI watch RSS
- Benaroya Research Institute portfolio CI